Axel Heitmann

Lanxess to Leave German DAX 30

The Steep Climb Back to Profit

Saltigo: 'Working Proactively With Trends'

Adaptability — A lot has happened in the world of custom manufacturing since Saltigo was carved out of Lanxess' fine chemicals business in 2006.

News

Slowly But Surely: Short-Interviews with Hans Wijers, Steven Sterin, Patrick Jany, Curt Espeland, Klaus Engel and Axel Heitmann

Top-Feature

Hamilton Bonaduz AG

Optimize Your Process with Smart Oxygen Sensors for Inertization and Blanketing Applications

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

CHEManager International c/o Wiley-VCH GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Free Expert Insights

Advancements in Bispecific Antibody Development

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

LANXESS Deutschland GmbH

Saltigo GmbH